Logopenic Progressive Aphasia
12
4
6
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 12 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease
Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia
Intervention for Communication Quality of Life in Primary Progressive Aphasia
Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease
Treatment for Speech and Language in Primary Progressive Aphasia
Primary Progressive Aphasia Multicomponent Language Treatment Study
Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA
Early-onset Alzheimer's Disease Phenotypes: Neuropsychology and Neural Networks
Home-Based Exercise in Primary Progressive Aphasia (HEPPA)
Can Magnetic Brain Stimulation Improve Language Function in Primary Progressive Aphasia
Tau Imaging in Young Onset Dementia